High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy
1997

High-Dose 5-Fluorouracil Infusion and Its Effects

Sample size: 280 publication Evidence: moderate

Author Information

Author(s): KH Yeh, AL Cheng

Primary Institution: Taiwan University Hospital

Hypothesis

High-dose 5-fluorouracil administration leads to hyperammonaemia and encephalopathy due to metabolic disruptions.

Conclusion

High-dose 5-fluorouracil treatment can cause severe encephalopathy linked to hyperammonaemia and lactic acidosis.

Supporting Evidence

  • 16 out of 280 patients developed encephalopathy after high-dose 5-FU treatment.
  • The incidence of encephalopathy was highest in gastric cancer patients at 12.1%.
  • All patients with encephalopathy recovered completely except one with partial hearing impairment.
  • Biochemical tests showed hyperammonaemia and lactic acidosis in patients with encephalopathy.

Takeaway

When patients get a lot of a cancer medicine called 5-fluorouracil, some can get really confused and sick because of too much ammonia in their blood.

Methodology

The study involved monitoring patients receiving high-dose 5-fluorouracil for signs of encephalopathy and measuring biochemical parameters.

Limitations

The study lacks direct evidence linking the biochemical changes to encephalopathy.

Participant Demographics

Patients treated at a single institution between 1991 and 1995, with a focus on those developing encephalopathy.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication